Status:

COMPLETED

StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Drug Poisoning

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary purpose of the protocol is to evaluate the StO2 performance measured at the admission to the emergency department to identify hemodynamic failure at the admission or within the first three...

Detailed Description

The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxy...

Eligibility Criteria

Inclusion

  • admitted to the emergency department,
  • whose pattern of hospitalization is drug poisoning, defined on data from the patient's interrogation or his family if the patient is not able to answer,
  • Written informed consent signed by the patient or, if he's unable to sign, by a companion,
  • Affiliated to medical insurance

Exclusion

  • Patients without thenar eminence or having a disease of the thenar,
  • Refusal to participate in the study,
  • Participation in another biomedical research,
  • Patient under guardianship, trusteeship or judicial protection,
  • Pregnant women or nursing mothers

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2014

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT01861262

Start Date

April 1 2013

End Date

February 1 2014

Last Update

July 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Toulouse

Toulouse, Midi-Pyrenees, France, 31059